FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2272820807> ?p ?o ?g. }

• W2272820807 endingPage "616" @default.
• W2272820807 startingPage "616" @default.
• W2272820807 abstract "Whole-exome sequencing (WES) has the potential to reveal tumor and germline mutations of clinical relevance, but the diagnostic yield for pediatric patients with solid tumors is unknown.To characterize the diagnostic yield of combined tumor and germline WES for children with solid tumors.Unselected children with newly diagnosed and previously untreated central nervous system (CNS) and non-CNS solid tumors were prospectively enrolled in the BASIC3 study at a large academic children's hospital during a 23-month period from August 2012 through June 2014. Blood and tumor samples underwent WES in a certified clinical laboratory with genetic results categorized on the basis of perceived clinical relevance and entered in the electronic health record.Clinical categorization of somatic mutations; frequencies of deleterious germline mutations related to patient phenotype and incidental medically-actionable mutations.Of the first 150 participants (80 boys and 70 girls, mean age, 7.4 years), tumor samples adequate for WES were available from 121 patients (81%). Somatic mutations of established clinical utility (category I) were reported in 4 (3%) of 121 patients, with mutations of potential utility (category II) detected in an additional 29 (24%) of 121 patients. CTNNB1 was the gene most frequently mutated, with recurrent mutations in KIT, TSC2, and MAPK pathway genes (BRAF, KRAS, and NRAS) also identified. Mutations in consensus cancer genes (category III) were found in an additional 24 (20%) of 121 tumors. Fewer than half of somatic mutations identified were in genes known to be recurrently mutated in the tumor type tested. Diagnostic germline findings related to patient phenotype were discovered in 15 (10%) of 150 cases: 13 pathogenic or likely pathogenic dominant mutations in adult and pediatric cancer susceptibility genes (including 2 each in TP53, VHL, and BRCA1), 1 recessive liver disorder with hepatocellular carcinoma (TJP2), and 1 renal diagnosis (CLCN5). Incidental findings were reported in 8 (5%) of 150 patients. Most patients harbored germline uncertain variants in cancer genes (98%), pharmacogenetic variants (89%), and recessive carrier mutations (85%).Tumor and germline WES revealed mutations in a broad spectrum of genes previously implicated in both adult and pediatric cancers. Combined reporting of tumor and germline WES identified diagnostic and/or potentially actionable findings in nearly 40% of newly diagnosed pediatric patients with solid tumors." @default.
• W2272820807 created "2016-06-24" @default.
• W2272820807 creator A5003575856 @default.
• W2272820807 creator A5004659186 @default.
• W2272820807 creator A5006293085 @default.
• W2272820807 creator A5007369881 @default.
• W2272820807 creator A5008633744 @default.
• W2272820807 creator A5012883015 @default.
• W2272820807 creator A5013433741 @default.
• W2272820807 creator A5016664176 @default.
• W2272820807 creator A5026512721 @default.
• W2272820807 creator A5028969570 @default.
• W2272820807 creator A5037749785 @default.
• W2272820807 creator A5041203888 @default.
• W2272820807 creator A5045889599 @default.
• W2272820807 creator A5046522785 @default.
• W2272820807 creator A5048951484 @default.
• W2272820807 creator A5055312193 @default.
• W2272820807 creator A5057009671 @default.
• W2272820807 creator A5057175194 @default.
• W2272820807 creator A5058400432 @default.
• W2272820807 creator A5059626751 @default.
• W2272820807 creator A5065618896 @default.
• W2272820807 creator A5065679041 @default.
• W2272820807 creator A5065741141 @default.
• W2272820807 creator A5068058971 @default.
• W2272820807 creator A5073398031 @default.
• W2272820807 creator A5074432182 @default.
• W2272820807 creator A5076494212 @default.
• W2272820807 creator A5078484599 @default.
• W2272820807 creator A5081863732 @default.
• W2272820807 creator A5083288793 @default.
• W2272820807 creator A5085142676 @default.
• W2272820807 creator A5089000102 @default.
• W2272820807 creator A5090391857 @default.
• W2272820807 date "2016-05-01" @default.
• W2272820807 modified "2023-10-17" @default.
• W2272820807 title "Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors" @default.
• W2272820807 cites W1974625077 @default.
• W2272820807 cites W1979855662 @default.
• W2272820807 cites W1980852206 @default.
• W2272820807 cites W1988303870 @default.
• W2272820807 cites W2012404242 @default.
• W2272820807 cites W2021341670 @default.
• W2272820807 cites W2021346554 @default.
• W2272820807 cites W2033198757 @default.
• W2272820807 cites W2035495486 @default.
• W2272820807 cites W2044433401 @default.
• W2272820807 cites W2064050001 @default.
• W2272820807 cites W2072931688 @default.
• W2272820807 cites W2076647600 @default.
• W2272820807 cites W2095787833 @default.
• W2272820807 cites W2112612051 @default.
• W2272820807 cites W2115160785 @default.
• W2272820807 cites W2118151336 @default.
• W2272820807 cites W2119818111 @default.
• W2272820807 cites W2124177066 @default.
• W2272820807 cites W2126633009 @default.
• W2272820807 cites W2128746885 @default.
• W2272820807 cites W2132546867 @default.
• W2272820807 cites W2134638008 @default.
• W2272820807 cites W2138956466 @default.
• W2272820807 cites W2141663748 @default.
• W2272820807 cites W2145922766 @default.
• W2272820807 cites W2156679982 @default.
• W2272820807 cites W2159415758 @default.
• W2272820807 cites W2162327089 @default.
• W2272820807 cites W2164984854 @default.
• W2272820807 cites W2181086016 @default.
• W2272820807 doi "https://doi.org/10.1001/jamaoncol.2015.5699" @default.
• W2272820807 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5471125" @default.
• W2272820807 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26822237" @default.
• W2272820807 hasPublicationYear "2016" @default.
• W2272820807 type Work @default.
• W2272820807 sameAs 2272820807 @default.
• W2272820807 citedByCount "354" @default.
• W2272820807 countsByYear W22728208072016 @default.
• W2272820807 countsByYear W22728208072017 @default.
• W2272820807 countsByYear W22728208072018 @default.
• W2272820807 countsByYear W22728208072019 @default.
• W2272820807 countsByYear W22728208072020 @default.
• W2272820807 countsByYear W22728208072021 @default.
• W2272820807 countsByYear W22728208072022 @default.
• W2272820807 countsByYear W22728208072023 @default.
• W2272820807 crossrefType "journal-article" @default.
• W2272820807 hasAuthorship W2272820807A5003575856 @default.
• W2272820807 hasAuthorship W2272820807A5004659186 @default.
• W2272820807 hasAuthorship W2272820807A5006293085 @default.
• W2272820807 hasAuthorship W2272820807A5007369881 @default.
• W2272820807 hasAuthorship W2272820807A5008633744 @default.
• W2272820807 hasAuthorship W2272820807A5012883015 @default.
• W2272820807 hasAuthorship W2272820807A5013433741 @default.
• W2272820807 hasAuthorship W2272820807A5016664176 @default.
• W2272820807 hasAuthorship W2272820807A5026512721 @default.
• W2272820807 hasAuthorship W2272820807A5028969570 @default.
• W2272820807 hasAuthorship W2272820807A5037749785 @default.
• W2272820807 hasAuthorship W2272820807A5041203888 @default.
• W2272820807 hasAuthorship W2272820807A5045889599 @default.

• next